Moxibustion for depression

BACKGROUND: Moxibustion, a traditional Chinese medicine therapy, is widely used for various diseases and has recently been applied in treating depression. This study aims to systematically assess the efficacy and safety of moxibustion, either alone or in combination with other therapies, for depression. METHODS: We conducted a comprehensive search across 7 databases from their inception to December 20, 2023, focusing on randomized controlled trials that compared moxibustion with sham treatments, no treatment, or conventional therapies. The primary outcomes were the overall effective rate and Hamilton Depression Rating Scale scores, with adverse reaction incidence as the secondary outcome. Data were analyzed with RevMan 5.4 and Stata 18, with bias risk assessed using the Cochrane Risk of Bias tool. Evidence quality was graded with GRADEpro. RESULTS: This study included 15 randomized controlled trials with 1510 patients. Meta-analysis results showed that moxibustion, alone or combined with other therapies, was more effective than other treatments for managing depression (relative risk = 1.07, 95% confidence interval [CI]: [1.03-1.10], P = .0003). Moxibustion, either alone or in combination with other treatments, significantly reduced Hamilton Depression Rating Scale scores compared to other treatments used alone (mean difference = -2.10, 95% CI: [-3.00 to -1.20]), with its efficacy comparable to that of antidepressant medications (mean difference = -0.60, 95% CI [-1.31 to 0.12], P = .10). Additionally, in terms of safety, the incidence of adverse reactions associated with moxibustion alone or in combination with other therapies for depression is relatively low (relative risk = 0.57, 95% CI: [0.39-0.84], P = .005). However, the overall quality of the evidence was assessed as low to very low. CONCLUSION: Moxibustion has been shown to alleviate depressive symptoms, particularly when combined with other therapies, offering both enhanced efficacy and safety. However, further high-quality studies are necessary to confirm its effectiveness.

Authors

Institutions

Publication Details

Journal
Medicine
Published
2026-10-16
DOI
https://doi.org/10.1097/md.0000000000051032
Primary Topic
Acupuncture Treatment Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Moxibustion for depression

Fengxia Sun, 刘增训, Xin Li, Aihua Yin et al.
Medicine
Acupuncture Treatment Research Studies
article

Moxibustion for depression

Fengxia Sun, 刘增训, Xin Li, Aihua Yin, Yijin Xie, Yingcun Li, Minling Li, Xu Li
article en

Abstract

BACKGROUND: Moxibustion, a traditional Chinese medicine therapy, is widely used for various diseases and has recently been applied in treating depression. This study aims to systematically assess the efficacy and safety of moxibustion, either alone or in combination with other therapies, for depression. METHODS: We conducted a comprehensive search across 7 databases from their inception to December 20, 2023, focusing on randomized controlled trials that compared moxibustion with sham treatments, no treatment, or conventional therapies. The primary outcomes were the overall effective rate and Hamilton Depression Rating Scale scores, with adverse reaction incidence as the secondary outcome. Data were analyzed with RevMan 5.4 and Stata 18, with bias risk assessed using the Cochrane Risk of Bias tool. Evidence quality was graded with GRADEpro. RESULTS: This study included 15 randomized controlled trials with 1510 patients. Meta-analysis results showed that moxibustion, alone or combined with other therapies, was more effective than other treatments for managing depression (relative risk = 1.07, 95% confidence interval [CI]: [1.03-1.10], P = .0003). Moxibustion, either alone or in combination with other treatments, significantly reduced Hamilton Depression Rating Scale scores compared to other treatments used alone (mean difference = -2.10, 95% CI: [-3.00 to -1.20]), with its efficacy comparable to that of antidepressant medications (mean difference = -0.60, 95% CI [-1.31 to 0.12], P = .10). Additionally, in terms of safety, the incidence of adverse reactions associated with moxibustion alone or in combination with other therapies for depression is relatively low (relative risk = 0.57, 95% CI: [0.39-0.84], P = .005). However, the overall quality of the evidence was assessed as low to very low. CONCLUSION: Moxibustion has been shown to alleviate depressive symptoms, particularly when combined with other therapies, offering both enhanced efficacy and safety. However, further high-quality studies are necessary to confirm its effectiveness.

MedicineVol. 105(42)
Shandong Mental Health Center (CN), Guangxi Zhuang Autonomous Region Brain Hospital (CN), Jining Medical University (CN)
Good health and well-being
Openalex Percentile: Top 7%
Acupuncture Treatment Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.